Transforming growth factor-beta (TGF-β1) genotype and lung allograft fibrosis

Journal of Heart and Lung Transplantation

Volumn 18, Issue 6, 1999, Pages 517-523

  El Gamel, Ahmed ^a   Awad, Mohammed R ^b   Hasleton, Philip S ^a   Yonan, Nizar A ^a   Hutchinson, James A ^c   Campbell, Colin S ^a   Rahman, Ali H ^a   Deiraniya, Abdul K ^a   Sinnott, Paul J ^b   Hutchinson, Ian V ^c  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; LEUCINE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; SURVIVAL RATE;

EID: 0033011393     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00024-2     Document Type: Article

References (17)

1. Khalil N., Greenberg A.H. The role of TGF-beta in pulmonary fibrosis. Ciba Found Symp. 157:1991;194-211.
2. Hirabayashi T., Demertzis S., Schafers J., et al. Chronic rejection in lung allografts immunohistological analysis of fibrogenesis . Transplant International. 9:(suppl. 1):1996;S293-S295.
3. Yousem S.A., Suncan S.R., Ohori N.P., Sonmez-Alpan E. Architectural remodeling of lung allografts in acute and chronic rejection [see comments]. Arch Pathol Lab Med. 116:1992;1175-1180.
4. Bienkowski R.S., Gotkin M.G. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med. 209:1995;118-140.
5. Patterson G.A. Double lung transplantation. Clin Chest Med. 11:1990;227-233.
6. Cooper J.D. The evolution of techniques and indications for lung transplantation. Ann Surg. 212:1990;249-255.
7. Sundaresan S., Trachiotis G.D., Aoe M., et al. Donor lung procurement assessment and operative technique [see comments] . Ann Thorac Surg. 56:1993;1409-1413.
8. Trulock E.P. Management of lung transplant rejection. Chest. 103:1993;1566-1576.
9. 1 and tumour necrosis factor-α Transplantation Immunol. 6:1998;193-197.
10. Ashchroft T., Simpson J., Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 41:1988;467.
11. Sitrin R.G., Brubaker P.G., Fantone J.C. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to pro coagulant and fibrinolytic activities. Am Rev Respir Dis. 135:1987;930-936.
12. McCullough B., Collins J.F. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. J Clin Invest. 61:1978;79-88.
13. Idell S., James K.U., Giles C., Fair D.S., Thrall R.S. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am J Pathol. 135:1989;387-399.
14. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnot P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Euro J Immunogenetics. 24:1997;1-8.
15. Crystal R. Interstitial lung disease. In: Wyngaarden JB, Jr SL, eds. Cecil text book of medicine. Philadelphia: WB Saunders, 1980, pp. 421-35.
16. Bingham K., Meyrick B. Interactions of granulocytes with the lungs. Circ Res. 54:1985;623-635.
17. Colvin R.B., Gardner P.I., Robbin R.O., Verderber E.L., et al. Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Lab Invest. 41:1979;464-472.